AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
PROTEIN-A IMMUNOADSORPTION IN ALLOIMMUNIZED PATIENTS REFRACTORY TO PLATELET TRANSFUSIONS AND IN PATIENTS WITH TREATMENT-RESISTANT IMMUNE THROMBOCYTOPOENIC PURPURA
Authors: GUTENSOHN K ZANDER AR ROWLEY SD HESTER J KUEHNL P
Citation: K. Gutensohn et al., PROTEIN-A IMMUNOADSORPTION IN ALLOIMMUNIZED PATIENTS REFRACTORY TO PLATELET TRANSFUSIONS AND IN PATIENTS WITH TREATMENT-RESISTANT IMMUNE THROMBOCYTOPOENIC PURPURA, Transfusion science, 19, 1998, pp. 47-52
NOVEL VASCULAR K-ATP CHANNEL BLOCKERS DERIVED FROM P1075-BASED CYANOGUANIDINE K-ATP OPENERS
Authors: MEISHERI K KHAN S HIGDON N HESTER J
Citation: K. Meisheri et al., NOVEL VASCULAR K-ATP CHANNEL BLOCKERS DERIVED FROM P1075-BASED CYANOGUANIDINE K-ATP OPENERS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 2825-2825
HEMATOPOIETIC SUPPORTIVE CARE
Authors: HESTER J
Citation: J. Hester, HEMATOPOIETIC SUPPORTIVE CARE, Clinical cancer research, 3(12), 1997, pp. 2666-2670
RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY (VOL 93, PG 15346, 1996)/
Authors: HANANIA EG GILES RE KAVANAGH J FU SQ ELLERSON D ZU Z WANG T SU Y KUDELKA A RAHMAN Z HOLMES F HORTOBAGYI G CLAXTON D BACHIER C THALL P CHENG S HESTER J OSTROVE JM BIRD RE CHANG A KORBLING M SEONG D COTE R HOLZMAYER T MECHETNER E HEIMFELD S BERENSON R BURTNESS B EDWARDS C BAST B ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY (VOL 93, PG 15346, 1996)/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(10), 1997, pp. 5495-5495
STELLAR POPULATIONS IN THE DWARF ELLIPTIC GALAXY NGC-147
Authors: HAN M HOESSEL JG GALLAGHER JS HOLTZMAN J STETSON PB TRAUGER J BALLESTER GE BURROWS C CLARKE J CRISP D GRIFFITHS R GRILLMAIR C HESTER J KRIST J MOULD JR SCOWEN P STAPELFELDT K WATSON A WESTPHAL J
Citation: M. Han et al., STELLAR POPULATIONS IN THE DWARF ELLIPTIC GALAXY NGC-147, The Astronomical journal, 113(3), 1997, pp. 1001
INTEGRATION OF BIOLOGICAL, PROCEDURAL, APHERESIS PRINCIPLES OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION PROGRAMS
Authors: HESTER J BOJKO P RONDON G CHAMPLIN R
Citation: J. Hester et al., INTEGRATION OF BIOLOGICAL, PROCEDURAL, APHERESIS PRINCIPLES OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION PROGRAMS, Transfusion science, 17(4), 1996, pp. 585-590
RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY/
Authors: HANANIA EG GILES RE KAVANAGH J ELLERSON D ZU Z WANG T SU Y KUDELKA A RAHMAN Z HOLMES F HORTOBAGYI G CLAXTON D BACHIER C THALL P CHENG S HESTER J OSTROVE JM BIRD RE CHANG A KORBLING M SEONG D COTE R HOLZMAYER T MECHETNER E HEIMFELD S BERENSON R BURTNESS B EDWARDS C BAST R ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY/, Proceedings of the National Academy of Sciences of the United Statesof America, 93(26), 1996, pp. 15346-15351
MYELOABLATIVE THERAPY FOR PRIMARY RESISTANT MULTIPLE-MYELOMA
Authors: ALEXANIAN R DIMOPOULOS MA DELASALLE KB HESTER J CHAMPLIN R
Citation: R. Alexanian et al., MYELOABLATIVE THERAPY FOR PRIMARY RESISTANT MULTIPLE-MYELOMA, Stem cells, 13, 1995, pp. 118-121
QUANTITATIVE EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN BY WESTERN-BLOT (PCNAWB) IN PERIPHERAL BLASTS CORRELATES WITH REMISSION INDUCTION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
Authors: DELGIGLIO A DRACH J KORNBLAU SM PATEL S NOVAES M KHETAN R SAWAYA N DORLHIACLLACER P CHAMONE DF ANDREEFF M HESTER J DEISSEROTH AB
Citation: A. Delgiglio et al., QUANTITATIVE EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN BY WESTERN-BLOT (PCNAWB) IN PERIPHERAL BLASTS CORRELATES WITH REMISSION INDUCTION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA, Leukemia & lymphoma, 19(3-4), 1995, pp. 235-241
CHEMOTHERAPY RESISTANCE TO TAXOL IN CLONOGENIC PROGENITOR CELLS FOLLOWING TRANSDUCTION OF CD34 SELECTED MARROW AND PERIPHERAL-BLOOD CELLS WITH A RETROVIRUS THAT CONTAINS THE MDR-1 CHEMOTHERAPY RESISTANCE GENE
Authors: HANANIA EG FU S ZU Z HEGEWISCHBECKER S KORBLING M HESTER J DURETT A ANDREEFF M MECHETNER E HOLZMAYER T RONINSON IB GILES RE BERENSON R HEIMFELD S DEISSEROTH AB
Citation: Eg. Hanania et al., CHEMOTHERAPY RESISTANCE TO TAXOL IN CLONOGENIC PROGENITOR CELLS FOLLOWING TRANSDUCTION OF CD34 SELECTED MARROW AND PERIPHERAL-BLOOD CELLS WITH A RETROVIRUS THAT CONTAINS THE MDR-1 CHEMOTHERAPY RESISTANCE GENE, Gene therapy, 2(4), 1995, pp. 285-294
COLLECTION OF PERIPHERAL-BLOOD DIPLOID-CELLS FROM CHRONIC MYELOGENOUSLEUKEMIA PATIENTS EARLY IN THE RECOVERY PHASE FROM MYELOSUPPRESSION INDUCED BY INTENSIVE-DOSE CHEMOTHERAPY
Authors: KANTARJIAN HM TALPAZ M HESTER J FELDMAN E KORBLING M LIANG J RIOS MB SMITH TL CALVERT L DEISSEROTH AB
Citation: Hm. Kantarjian et al., COLLECTION OF PERIPHERAL-BLOOD DIPLOID-CELLS FROM CHRONIC MYELOGENOUSLEUKEMIA PATIENTS EARLY IN THE RECOVERY PHASE FROM MYELOSUPPRESSION INDUCED BY INTENSIVE-DOSE CHEMOTHERAPY, Journal of clinical oncology, 13(3), 1995, pp. 553-559
CD8 DEPLETED DONOR LYMPHOCYTES FOR CML RELAPSING POST BMT
Authors: CHAMPLIN R GIRALT S GAJEWSKI J HESTER J KORBLING M DEISSEROTH A
Citation: R. Champlin et al., CD8 DEPLETED DONOR LYMPHOCYTES FOR CML RELAPSING POST BMT, Experimental hematology, 23(8), 1995, pp. 939-939
HOMOHARRINGTONINE THERAPY INDUCES RESPONSES IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN LATE CHRONIC PHASE
Authors: OBRIEN S KANTARJIAN H KEATING M BERAN M KOLLER C ROBERTSON LE HESTER J RIOS M ANDREEFF M TALPAZ M
Citation: S. Obrien et al., HOMOHARRINGTONINE THERAPY INDUCES RESPONSES IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN LATE CHRONIC PHASE, Blood, 86(9), 1995, pp. 3322-3326
CD8-DEPLETED DONOR LYMPHOCYTE INFUSION AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: GIRALT S HESTER J HUH Y HIRSCHGINSBERG C RONDON G SEONG D LEE M GAJEWSKI J VANBESIEN K KHOURI I MEHRA R PRZEPIORKA D KORBLING M TALPAZ M KANTARJIAN H FISCHER H DEISSEROTH A CHAMPLIN R
Citation: S. Giralt et al., CD8-DEPLETED DONOR LYMPHOCYTE INFUSION AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(11), 1995, pp. 4337-4343
PERCENTAGE OF PHILADELPHIA-CHROMOSOME (PH)-NEGATIVE AND PH-POSITIVE CELLS FOUND AFTER AUTOLOGOUS TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA DEPENDS ON PERCENTAGE OF DIPLOID-CELLS INDUCED BY CONVENTIONAL-DOSE CHEMOTHERAPY BEFORE COLLECTION OF AUTOLOGOUS CELLS
Authors: TALPAZ M KANTARJIAN H LIANG J CALVERT L HAMER J TIBBITS P DURETT A CLAXTON D GIRALT S KHOURI I PRZEPIORKA D VANBESIEN K ANDERSSON B MEHRA R GAJEWSKI J SEONG D HESTER J ESTEY E KORBLING M POLLICARDO N BERENSON R HEIMFELD S CHAMPLIN R DEISSEROTH AB
Citation: M. Talpaz et al., PERCENTAGE OF PHILADELPHIA-CHROMOSOME (PH)-NEGATIVE AND PH-POSITIVE CELLS FOUND AFTER AUTOLOGOUS TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA DEPENDS ON PERCENTAGE OF DIPLOID-CELLS INDUCED BY CONVENTIONAL-DOSE CHEMOTHERAPY BEFORE COLLECTION OF AUTOLOGOUS CELLS, Blood, 85(11), 1995, pp. 3257-3263
HUBBLE-SPACE-TELESCOPE IMAGING OF THE WIND-BLOWN LOBE NGC-165
Authors: SCOWEN P HESTER J CODE A MACKIE G LYNDS CR ONEIL EJ
Citation: P. Scowen et al., HUBBLE-SPACE-TELESCOPE IMAGING OF THE WIND-BLOWN LOBE NGC-165, The Astrophysical journal, 450(1), 1995, pp. 196-200
INTENSIVE SEQUENTIAL THERAPY FOR VAD-RESISTANT MULTIPLE-MYELOMA
Authors: DIMOPOULOS MA WEBER DM HESTER J DELASALLE K CHAMPLIN R ALEXANIAN R
Citation: Ma. Dimopoulos et al., INTENSIVE SEQUENTIAL THERAPY FOR VAD-RESISTANT MULTIPLE-MYELOMA, Leukemia & lymphoma, 13(5-6), 1994, pp. 479-484
CD8+ LYMPHOCYTES ARE NOT ESSENTIAL FOR GRAFT VS LEUKEMIA IN CHRONIC MYELOGENOUS LEUKEMIA
Authors: GIRALT S HESTER J RONDON G HUH Y GAJEWSKI J TALPAZ M KANTARJIAN H DEISSEROTH A CHAMPLIN R
Citation: S. Giralt et al., CD8+ LYMPHOCYTES ARE NOT ESSENTIAL FOR GRAFT VS LEUKEMIA IN CHRONIC MYELOGENOUS LEUKEMIA, Experimental hematology, 22(8), 1994, pp. 697-697
HIGH-DOSES OF CYCLOPHOSPHAMIDE, ETOPOSIDE AND TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN THE MANAGEMENT OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
Authors: TALPAZ M ANDERSSON B KHOURI I GIRALT S RIOS MB KANTARJIAN HM CHAMPLIN R HESTER J DEISSEROTH AB
Citation: M. Talpaz et al., HIGH-DOSES OF CYCLOPHOSPHAMIDE, ETOPOSIDE AND TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN THE MANAGEMENT OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA, Bone marrow transplantation, 14(1), 1994, pp. 57-61
INTENSIVE CHEMOTHERAPY WITH BLOOD PROGENITOR TRANSPLANTATION FOR PRIMARY RESISTANT MULTIPLE-MYELOMA
Authors: DIMOPOULOS MA HESTER J HUH Y CHAMPLIN R ALEXANIAN R
Citation: Ma. Dimopoulos et al., INTENSIVE CHEMOTHERAPY WITH BLOOD PROGENITOR TRANSPLANTATION FOR PRIMARY RESISTANT MULTIPLE-MYELOMA, British Journal of Haematology, 87(4), 1994, pp. 730-734
EARLY MYELOABLATIVE THERAPY FOR MULTIPLE-MYELOMA
Authors: ALEXANIAN R DIMOPOULOS MA HESTER J DELASALLE K CHAMPLIN R
Citation: R. Alexanian et al., EARLY MYELOABLATIVE THERAPY FOR MULTIPLE-MYELOMA, Blood, 84(12), 1994, pp. 4278-4282
EARLY MYELOABLATIVE THERAPY FOR MULTIPLE-MYELOMA
Authors: ALEXANIAN R DIMOPOULOS M HESTER J DELASALLE K CHAMPLIN R
Citation: R. Alexanian et al., EARLY MYELOABLATIVE THERAPY FOR MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 10000182-10000182
COLLECTION OF PERIPHERAL-BLOOD DIPLOID-CELLS FROM CHRONIC MYELOGENOUSLEUKEMIA PATIENTS (PTS) EARLY IN THE RECOVERY PHASE FROM MYELOSUPPRESSION INDUCED BY INTENSIVE CHEMOTHERAPY
Authors: KANTARJIAN H TALPAZ M HESTER J LIANG J DEISSEROTH A
Citation: H. Kantarjian et al., COLLECTION OF PERIPHERAL-BLOOD DIPLOID-CELLS FROM CHRONIC MYELOGENOUSLEUKEMIA PATIENTS (PTS) EARLY IN THE RECOVERY PHASE FROM MYELOSUPPRESSION INDUCED BY INTENSIVE CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000382-10000382
DIPLOID-CELLS COLLECTED FROM CHRONIC MYELOGENOUS LEUKEMIA PATIENTS DURING RECOVERY FROM CONVENTIONAL DOSE-INDUCED MYELOSUPPRESSION GENERATECOMPLETE CYTOGENETIC REMISSIONS AFTER AUTOLOGOUS TRANSPLANTATION
Authors: TALPAZ M KANTARJIAN H KHOURI I GAJEWSKI J PRZEPIORKA D GIRALT S MEHRA R VANBESIEN K CLAXTON D ANDERSSON B HESTER J KORBLING M BERENSON R HEIMFELD S CALVERT L HAMER J TIBBITS P LIANG J CHAMPLIN R DEISSEROTH AB
Citation: M. Talpaz et al., DIPLOID-CELLS COLLECTED FROM CHRONIC MYELOGENOUS LEUKEMIA PATIENTS DURING RECOVERY FROM CONVENTIONAL DOSE-INDUCED MYELOSUPPRESSION GENERATECOMPLETE CYTOGENETIC REMISSIONS AFTER AUTOLOGOUS TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000537-10000537
CD8-MARROW TRANSPLANTATION (BMT) - GRAFT VS LEUKEMIA WITHOUT GRAFT-VS-HOST DISEASE (GVHD)( DEPLETED DONOR LYMPHOCYTE INFUSION AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER ALLOGENEIC BONE)
Authors: GIRALT S HESTER J HUH Y HIRSCHGINSBERG C RONDON G GUO J LEE M GAJEWSKI J TALPAZ M KANTARJIAN H FISCHER H DEISSEROTH A CHAMPLIN R
Citation: S. Giralt et al., CD8-MARROW TRANSPLANTATION (BMT) - GRAFT VS LEUKEMIA WITHOUT GRAFT-VS-HOST DISEASE (GVHD)( DEPLETED DONOR LYMPHOCYTE INFUSION AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER ALLOGENEIC BONE), Blood, 84(10), 1994, pp. 10000538-10000538
Risultati: 1-25 | 26-34